Fertility control with Ovral. A clinical review.
D000152:Acne Vulgaris / Q000139:chemically induced; D000284:Administration, Oral; D000311:Adrenal Glands / Q000187:drug effects; D000568:Amenorrhea / Q000139:chemically induced; D002277:Carcinoma / Q000139:chemically induced; D002584:Cervix Uteri / Q000166:cytology / Q000187:drug effects; D003276:Contraceptives, Oral / Q000008:administration & dosage*; D004338:Drug Combinations; D004412:Dysmenorrhea / Q000139:chemically induced; D004997:Ethinyl Estradiol / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects; D008598:Menstruation / Q000187:drug effects; D009325:Nausea / Q000139:chemically induced; D009644:Norgestrel / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D013924:Thrombophlebitis / Q000139:chemically induced; D013961:Thyroid Gland / Q000187:drug effects; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced
D003276:Contraceptives, Oral; D004338:Drug Combinations; D009644:Norgestrel; D004997:Ethinyl Estradiol